Front Desk: 469-391-0070
Deferasirox: Comprehensive Guide to Iron Chelation Therapy
Summary or Key Points
Deferasirox is a medication used to manage iron overload in individuals with conditions such as thalassemia, sickle cell disease, and other disorders that require frequent blood transfusions. It helps the body eliminate excess iron, which can build up in organs and cause damage. Always consult your healthcare provider before starting or adjusting your dose. Our telemedicine providers are available to assist with managing your treatment.
Names of Medication
US Brand Name: Exjade, Jadenu
Generic Name: Deferasirox
The generic name refers to the active ingredient in the medication, which remains consistent across different brands. In this case, the generic name is Deferasirox.
Pharmacologic Category
Category: Iron Chelating Agent
Deferasirox Dosage
Deferasirox is prescribed to treat various conditions related to iron overload. The dosage and frequency depend on the specific condition being treated. Always follow your doctor’s instructions and consult them before making any changes to your dose. Our telemedicine providers are available to address any concerns about your treatment plan.
Iron Overload Due to Repeated Blood Transfusions
Initial Dose: 20 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Ongoing treatment, monitored by your healthcare provider.
Thalassemia
Initial Dose: 10 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Long-term treatment, adjusted based on iron levels and response to therapy.
Sickle Cell Disease
Initial Dose: 10-20 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Ongoing treatment, monitored by your healthcare provider.
Myelodysplastic Syndromes
Initial Dose: 10-20 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Long-term treatment, adjusted based on iron levels and response to therapy.
Chronic Liver Disease
Initial Dose: 10 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Ongoing treatment, monitored by your healthcare provider.
Hemochromatosis
Initial Dose: 10 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Long-term treatment, adjusted based on iron levels and response to therapy.
Beta-Thalassemia
Initial Dose: 10-20 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Ongoing treatment, monitored by your healthcare provider.
Aplastic Anemia
Initial Dose: 10 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Long-term treatment, adjusted based on iron levels and response to therapy.
Chronic Kidney Disease
Initial Dose: 10 mg/kg once daily
Maximum Dose: 40 mg/kg once daily
Duration: Ongoing treatment, monitored by your healthcare provider.
Dosage Forms and Strengths
Tablets for Oral Suspension: 125 mg, 250 mg, 500 mg
Film-coated Tablets: 90 mg, 180 mg, 360 mg
Granules: 90 mg, 180 mg, 360 mg
Administration Instructions for Deferasirox
Deferasirox should be taken once daily, ideally at the same time each day. The tablets for oral suspension should be dissolved in water or juice and taken on an empty stomach, at least 30 minutes before eating. The film-coated tablets and granules can be taken with or without food. Always follow your healthcare provider’s instructions on how to take this medication. If you have any questions, our telemedicine providers are available to assist you.
Deferasirox Side Effects and Adverse Reactions
Like all medications, Deferasirox may cause side effects. Some are common and mild, while others are rare but more serious. If you experience any side effects, contact your healthcare provider promptly.
Common Side Effects: Nausea, vomiting, diarrhea, and abdominal pain. These are typically mild and may improve over time.
Less Common Side Effects: Skin rash, itching, and headaches. These may require medical attention if they persist.
Serious Side Effects: Kidney problems, liver issues, and gastrointestinal bleeding. These are rare but require immediate medical attention.
Contraindications for Deferasirox
A contraindication is a specific condition or situation where a medication should not be used because it may cause harm. It is important to be aware of these conditions to avoid serious side effects or complications. Below are the contraindications for taking Deferasirox:
Severe kidney disease: Deferasirox is processed through the kidneys, and if you have severe kidney problems, the medication may not be cleared properly, leading to toxic levels.
Severe liver disease: Since Deferasirox is metabolized by the liver, patients with severe liver disease may experience worsened liver function or failure.
Low platelet count (thrombocytopenia): Deferasirox can further lower platelet counts, increasing the risk of bleeding.
Allergy to Deferasirox: If you have had an allergic reaction to Deferasirox or any of its ingredients, taking the medication again could result in a severe allergic reaction.
Advanced cancers: Deferasirox may not be suitable for patients with certain advanced cancers, as it could interfere with other treatments or worsen the condition.
Drug to Drug Interactions with Deferasirox
Deferasirox can interact with other medications, increasing the risk of side effects or reducing the effectiveness of either drug. Inform your healthcare provider of all medications you are taking. Below are some key medications that interact with Deferasirox:
Antacids containing aluminum (e.g., Maalox, Gaviscon): These can reduce the effectiveness of Deferasirox by binding to the drug in your stomach.
Corticosteroids (e.g., Prednisone): These may increase the risk of kidney problems when taken with Deferasirox.
Nonsteroidal anti-inflammatory drugs (NSAIDs) (e.g., Ibuprofen, Advil): Taking NSAIDs with Deferasirox can increase the risk of stomach bleeding and kidney issues.
Blood thinners (e.g., Warfarin, Coumadin): Deferasirox may increase the risk of bleeding when taken with blood thinners.
Cyclosporine (e.g., Neoral, Sandimmune): This immune-suppressing drug can increase the risk of kidney damage when taken with Deferasirox.
html
Deferasirox in Pregnancy
Is it safe to take Deferasirox when pregnant?
Deferasirox is generally not recommended during pregnancy unless absolutely necessary. Animal studies have shown potential harm to the fetus, and there is limited information on its safety in pregnant women. If you are pregnant or planning to become pregnant, it’s essential to discuss the risks and benefits with your healthcare provider. Together, you can carefully weigh the potential risks to your baby against the benefits of treating iron overload with Deferasirox.
Deferasirox while Breastfeeding
Is it safe to take Deferasirox while breastfeeding?
It is unclear whether Deferasirox passes into breast milk. Due to the possibility of serious side effects in a nursing infant, it is generally advised to avoid breastfeeding while taking this medication. If you are breastfeeding or planning to breastfeed, consult your healthcare provider to explore alternative treatments or discuss whether you should stop breastfeeding while on Deferasirox.
Estimated Cost of Deferasirox
The cost of Deferasirox can vary depending on the dosage and the pharmacy. Without insurance, the estimated price for a 30-day supply using a GoodRx coupon ranges from $1,500 to $2,500. Be sure to check with your pharmacy and explore discount programs that may help reduce the cost of your medication.
Possible Alternatives to Deferasirox
Depending on your condition, alternative treatments or lifestyle changes may help manage iron overload. Always consult your healthcare provider before making any adjustments to your treatment plan. For personalized guidance, you can schedule a telemedicine appointment with one of our providers.
Iron Overload Treatment Options
In addition to Deferasirox, other iron chelators such as deferoxamine (Desferal) or deferiprone (Ferriprox) may be considered. Phlebotomy (blood removal) is another option for some patients. Dietary changes, such as reducing the intake of iron-rich foods, may also help manage iron overload.
Thalassemia Treatment Options
Standard treatments for thalassemia include blood transfusions and iron chelation therapy. In some cases, a bone marrow transplant may be an option. Lifestyle changes, such as avoiding iron supplements and following a low-iron diet, can also be beneficial.
Sickle Cell Disease Management
Common treatments for sickle cell disease include hydroxyurea and blood transfusions. Managing pain, staying well-hydrated, and avoiding triggers like extreme temperatures can help reduce symptoms and improve quality of life.
Myelodysplastic Syndromes Treatment
Treatment for myelodysplastic syndromes may involve blood transfusions, medications like lenalidomide (Revlimid), or bone marrow transplants. Iron chelation therapy, such as Deferasirox, is often used to manage iron overload in these patients.
Chronic Liver Disease and Iron Overload
Managing the underlying cause of liver disease is crucial. Iron chelation therapy may be used to reduce iron levels in patients with chronic liver disease. Additionally, avoiding alcohol and maintaining a healthy diet can help protect liver function.
Hemochromatosis Treatment
Phlebotomy is the primary treatment for hemochromatosis. If phlebotomy is not an option, iron chelation therapy, such as Deferasirox, may be considered. Dietary changes, including avoiding iron-rich foods and vitamin C supplements, can also help manage iron levels.
Beta-Thalassemia Treatment
Blood transfusions and iron chelation therapy are common treatments for beta-thalassemia. In some cases, a bone marrow transplant may be a viable option.
Aplastic Anemia Management
Treatment for aplastic anemia may include blood transfusions, immunosuppressive therapy, or bone marrow transplants. Iron chelation therapy, such as Deferasirox, may be used to manage iron overload resulting from frequent transfusions.
Chronic Kidney Disease and Iron Overload
Managing chronic kidney disease often involves controlling blood pressure and blood sugar levels. If iron overload occurs due to frequent blood transfusions, iron chelation therapy may be necessary.
Iron Overload from Repeated Blood Transfusions
In addition to Deferasirox, other iron chelators like deferoxamine (Desferal) or deferiprone (Ferriprox) may be used to manage iron overload from repeated blood transfusions. Regular monitoring of iron levels is essential to prevent complications.
Recent Updates on Deferasirox Research
Recent studies have focused on improving the safety and effectiveness of Deferasirox. Ongoing research aims to better understand how to minimize side effects, particularly those affecting kidney and liver function. New formulations, such as dispersible tablets, have been developed to enhance patient compliance and reduce gastrointestinal side effects. Additionally, studies are examining the long-term outcomes of patients using Deferasirox for conditions like thalassemia and sickle cell disease. As research continues to evolve, staying informed about new developments is important. Be sure to discuss any new findings with your healthcare provider, and if you have questions, our telemedicine team is here to assist you.
